Clinical Trial Update: Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer

View source ↗

Summary

A completed clinical trial update investigates cancer therapy-related cardiac dysfunction associated with EGFR-TKIs in advanced EGFR-mutant non-small cell lung …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Afatinib (afatinib)
• ERLOTINIB (Erlotinib)
• Gefitinib (Gefitinib)
• Osimertinib (osimertinib)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Non-Small Cell Lung Cancer (MeSH Term: Carcinoma, Non-Small-Cell Lung), Drug-Related Side Effects and Adverse Reactions (MeSH Term) | Status: COMPLETED